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Feed additives are commonly used to improve pig performance and health, but they need to be 
tested so new biomarkers for intestinal health, non- or minimally invasive, are under 
investigations. 
The quantification of Myeloperoxidase (MPO) and Pancreatitis Associated Protein (PAP) in feces 
could prove useful to non-invasively monitor intestinal health (Niewold, 2015). MPO is an 
enzyme that permits to quantify the number of inflammatory cells present in tissues and feces 
(Prokopowicz et al., 2012) , while PAP is a protein mainly produced in the small intestine with 
anti-inflammatory and bactericidal activity (Cash et al., 2006; Mukherjee et al., 2014). Because of 
the lack of a commercial ELISA kit for porcine PAP detection, the main aim of this study was to 
develop and validate a new sandwich ELISA test for the quantification of PAP in pig fecal 
samples. Our study consisted of two phases: test development (Figure 1) and test validation. 
During the development phase we used polyclonal antibodies previously immunized from rabbit 
serum with a pure peptide containing the N-terminus of pig PAP (Soler et al., 2015). The 
validation of the test was then performed with fecal extraction samples derived from animals 
with known high or low growth performance. 
Moreover, the temperature stability of PAP in feces and the optimal extraction method was 
tested. Even if only preliminary, our results seem to show a fair relationship between fecal 
consistency, used as health indicator, and PAP fecal concentrations. Furthermore, no relevant 
differences in PAP concentration after 24h of incubation at 37 °C, 4°C or room temperature were 
detected. 
To date, the present results suggest that PAP seems to be exceptionally stable in feces and is a 
very promising candidate as a non-invasive (fecal) biomarker for intestinal health and growth. 
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Figure 1:   Standard curves with absorbance at 405 nm versus log 2 RegIIIγ peptide concentration (µg/ml). Capture 
antibody concentrations used were 10 µg/ml (           ); 5 µg/ml ml (           ); 3.125 µg/ml (             ) and 0 µg/ml (           ). 
Detection antibody concentration used was 5 µg/ml. 
